Researchers are excited about the medication , a novel dual agonist showing significant results in initial trials for weight reduction . It functions by impacting both pathways : GLP-1 and GIP, these, https://lewisnelg707288.59bloggers.com/41116163/this-new-hope-for-weight-reduction